Vitamin D and multiple health outcomes in the Harvard cohorts

Molecular Nutrition and Food Research

Volumn 54, Issue 8, 2010, Pages 1114-1126

  Wei, Melissa Y ^a   Giovannucci, Edward L ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

25 Hydroxyvitamin D; Cancer; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; CALCITRIOL RECEPTOR; VITAMIN D;

ADULT; BLOOD; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIET; DIET SUPPLEMENTATION; FEMALE; FRACTURE; GENETIC POLYMORPHISM; GENETICS; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MALE; MULTIPLE SCLEROSIS; NEOPLASM; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; ADULT; CALCIFEDIOL; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; FRACTURES, BONE; HEALTH SURVEYS; HUMANS; MALE; MULTIPLE SCLEROSIS; NEOPLASMS; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77955885718     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900574     Document Type: Review

References (64)

1. McKenna, M. J., Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 1992, 93, 69-93.
2. Holick, M. F., Vitamin D deficiency. New Engl. J. Med. 2007, 357, 266-281.
3. Chapuy, M. C., Preziosi, P., Maamer, M., Arnaud, S., et al., Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7, 439-443.
4. Malabanan, A., Veronikis, I. E., Holick, M. F., Redefining vitamin D insufficiency. Lancet 1998, 351, 805-806.
5. Holick, M. F., High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 2006, 81, 353-373.
6. Holick, M. F., Chen, T. C., Lu, Z., Sauter, E., Vitamin D and skin physiology: a D-lightful story. J. Bone Miner. Res. 2007, 22, V28-V33.
7. Holick, M. F. In: Favus, M. J. (Ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, American Society for Bone Mineral Research, Washington, DC 2006, pp. 129-137.
8. Garland, F. C., Garland, C. F., Gorham, E. D., Young, J. F., Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 1990, 19, 614-622.
9. Forman, J. P., Curhan, G. C., Taylor, E. N., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008, 52, 828-832.
10. Giovannucci, E., Liu, Y., Hollis, B. W., Rimm, E. B., 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Internal Med. 2008, 168, 1174-1180.
11. Forman, J. P., Giovannucci, E., Holmes, M. D., Bischoff-Ferrari, H. A. et al., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49, 1063-1069.
12. Peterlik, M., Cross, H. S., Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur. J. Clin. Invest. 2005, 35, 290-304.
13. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E. et al., Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29, 726-776.
14. Giovannucci, E., Vitamin D and cancer incidence in the Harvard cohorts. Ann. Epidemiol. 2009, 19, 84-88.
15. Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., Ascherio, A., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 2006, 296, 2832-2838.
16. Garland, C. F., Garland, F. C., Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 1980, 9, 227-231.
17. Lefkowitz, E. S., Garland, C. F., Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int. J. Epidemiol. 1994, 23, 1133-1136.
18. Seifert, M., Tilgen, W., Reichrath, J., Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res. 2009, 29, 3659-3667.
19. Revelli, A., Massobrio, M., Tesarik, J., Nongenomic effects of 1alpha,25-dihydroxyvitamin D(3). Trends Endocrinol. Metab. TEM 1998, 9, 419-427.
20. Farach-Carson, M. C., Ridall, A. L., Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: crosstalk between genomic and membrane-initiated pathways. Am. J. Kidney Dis. 1998, 31, 729-742.
21. Platz, E. A., Rimm, E. B., Willett, W. C., Kantoff, P. W., Giovannucci, E., Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J. Natl. Cancer Inst. 2000, 92, 2009-2017.
22. Zittermann, A., Koerfer, R., Vitamin D in the prevention and treatment of coronary heart disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 752-757.
23. Li, Y. C., Kong, J., Wei, M., Chen, Z. F. et al., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin- angiotensin system. J. Clin. Invest. 2002, 110, 229-238.
24. Zhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D., Miao, D., Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008, 74, 170-179.
25. Pilz, S., Tomaschitz, A., Ritz, E., Pieber, T. R., Vitamin D status and arterial hypertension: a systematic review. Nature Rev. 2009, 6, 621-630.
26. Giovannucci, E., Liu, Y., Rimm, E. B., Hollis, B. W. et al., Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl. Cancer Inst. 2006, 98, 451-459.
27. Forman, J. P., Bischoff-Ferrari, H. A., Willett, W. C., Stampfer, M. J., Curhan, G. C., Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 2005, 46, 676-682.
28. Holick, M. F., Diabetes and the vitamin D connection. Curr. Diab. Rep. 2008, 8, 393-398.
29. Pittas, A. G., Lau, J., Hu, F. B., Dawson-Hughes, B., The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92, 2017-2029.
30. Wu, T., Willett, W. C., Giovannucci, E., Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men. J. Nutr. 2009, 139, 547-554.
31. Peterlik, M., Grant, W. B., Cross, H. S., Calcium, vitamin D and cancer. Anticancer Res. 2009, 29, 3687-3698.
32. Giovannucci, E., The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005, 16, 83-95.
33. Oh, K., Willett, W. C., Wu, K., Fuchs, C. S., Giovannucci, E. L., Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am. J. Epidemiol. 2007, 165, 1178-1186.
34. Kampman, E., Giovannucci, E., van't Veer, P., Rimm, E. et al., Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am. J. Epidemiol. 1994, 139, 16-29.
35. Kearney, J., Giovannucci, E., Rimm, E. B., Ascherio, A. et al., Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am. J. Epidemiol. 1996, 143, 907-917.
36. Martinez, M. E., Giovannucci, E. L., Colditz, G. A., Stampfer, M. J. et al., Calcium, vitamin D, and the occurrence of colorectal cancer among women. J. Natl. Cancer Inst. 1996, 88, 1375-1382.
37. Wu, K., Feskanich, D., Fuchs, C. S., Willett, W. C. et al., A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J. Natl. Cancer Inst. 2007, 99, 1120-1129.
38. Platz, E. A., Hankinson, S. E., Hollis, B. W., Colditz, G. A. et al., Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol. Biomarkers Prev. 2000 9, 1059-1065.
39. Ng, K., Wolpin, B. M., Meyerhardt, J. A., Wu, K. et al., Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br. J. Cancer 2009, 101, 916-923.
40. Bertone-Johnson, E. R., Chen, W. Y., Holick, M. F., Hollis, B. W. et al., Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1991-1997.
41. Shin, M. H., Holmes, M. D., Hankinson, S. E., Wu, K. et al., Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J. Natl. Cancer Inst. 2002, 94, 1301-1311.
42. Gann, P. H., Ma, J., Hennekens, C. H., Hollis, B. W. et al., Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 1996, 5, 121-126.
43. Platz, E. A., Leitzmann, M. F., Hollis, B. W., Willett, W. C., Giovannucci, E., Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004, 15, 255-265.
44. Giovannucci, E., Rimm, E. B., Wolk, A., Ascherio, A. et al., Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998, 58, 442-447.
45. Skinner, H. G., Michaud, D. S., Giovannucci, E., Willett, W. C. et al., Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1688-1695.
46. Pierrot-Deseilligny, C., Clinical implications of a possible role of vitamin D in multiple sclerosis. J. Neurol. 2009, 256, 1468-1479.
47. Kurtzke, J. F., MS epidemiology world wide. One view of current status. Acta Neurol. Scand. 1995, 161, 23-33.
48. van der Mei, I. A., Ponsonby, A. L., Blizzard, L., Dwyer, T., Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001, 20, 168-174.
49. Munger, K. L., Zhang, S. M., O'Reilly, E., Hernan, M. A. et al., Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62, 60-65.
50. Jurutka, P. W., Bartik, L., Whitfield, G. K., Mathern, D. R. et al., Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J. Bone Miner. Res. 2007, 22, 2-10.
51. Chiang, K. C., Persons, K. S., Istfan, N. W., Holick, M. F., Chen, T. C., Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells. Anticancer 2009, 29, 3591-3596.
52. Feskanich, D., Willett, W. C., Colditz, G. A., Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am. J. Clin. Nutr. 2003, 77, 504-511.
53. Bischoff-Ferrari, H. A., Willett, W. C., Wong, J. B., Stuck, A. E. et al., Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch. Internal Med. 2009, 169, 551-561.
54. Yin, L., Grandi, N., Raum, E., Haug, U. et al., Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment. Pharmacol. Therapeut. 2009, 30, 113-125.
55. Wang, T. J., Pencina, M. J., Booth, S. L., Jacques, P. F. et al., Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117, 503-511.
56. Dobnig, H., Pilz, S., Scharnagl, H., Renner, W. et al., Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Internal Med. 2008, 168, 1340-1349.
57. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes: for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, DC 1997.
58. Hathcock, J. N., Shao, A., Vieth, R., Heaney, R., Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85, 6-18.
59. DeLuca, H. F., Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80, 1689S-1696S.
60. Hollis, B. W., Wagner, C. L., Assessment of dietary vitamin D requirements during pregnancy and lactation. Am. J. Clin. Nutr. 2004, 79, 717-726.
61. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 2003, 42, S1-S201.
62. Holick, M. F., Vitamin D for health and in chronic kidney disease. Semin. Dial. 2005, 18, 266-275.
63. Vieth, R., Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 575-579.
64. Holick, E. A., Lu., Z., Holick, M. T., Chen, T. C., Sheperd, J., Holick, M. F., In: Holick, M. F. (Ed.), Biologic Effects of Light 2001: Proceedings of a Symposium. Kluwer Academic, Boston, MA 2002, pp. 205-212